We therefore selected the 8t28Z design for further analysis, based on prior reports indicating that IFN-γ secretion can modulate the tumor microenvironment of solid tumors and increase the efficacy of CAR-T cells (27, 28). The gene discussed is IFNG; the disease is neoplasm.